SCHEMBL21395795

SCHEMBL21395795

N#Cc1ccc2oc3ccc(-c4ccc(-c5ccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)cc5)cc4)cc3c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.45
ALDH1A1 P00352 3/20 0.45
CYP1A2 P05177 3/20 0.45
KMT2A Q03164 3/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C19 P33261 2/20 0.45
CLK4 Q9HAZ1 2/20 0.45
LMNA P02545 2/20 0.45
TSHR P16473 2/20 0.45
HSD17B10 Q99714 2/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
ABCG2 Q9UNQ0 9/20 0.45
ABCB1 P08183 4/20 0.45
PGR P06401 2/20 0.43
MAPK1 P28482 1/20 0.42
KDM4E B2RXH2 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
TNKS O95271 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21395933 1.00 MEN1 (0.45) MEN1ALDH1A1CYP1A2KMT2ACYP3A4
SCHEMBL21342517 0.99 MEN1 (0.46) MEN1ALDH1A1CYP1A2KMT2ACYP3A4
SCHEMBL21396136 0.97 ALDH1A1 (0.47) MEN1ALDH1A1CYP1A2KMT2ACYP3A4
SCHEMBL21395736 0.97 ALDH1A1 (0.47) MEN1ALDH1A1CYP1A2KMT2ACYP3A4
SCHEMBL21148271 0.96 CYP1A2 (0.47) MEN1ALDH1A1CYP1A2KMT2ACYP3A4
SCHEMBL21395831 0.96 CYP1A2 (0.47) MEN1ALDH1A1CYP1A2KMT2ACYP3A4
SCHEMBL21395794 0.96 ABCG2 (0.49) MEN1ALDH1A1CYP1A2KMT2ACYP3A4
SCHEMBL21395945 0.96 ABCG2 (0.49) MEN1ALDH1A1CYP1A2KMT2ACYP3A4
SCHEMBL21395943 0.96 ABCG2 (0.49) MEN1ALDH1A1CYP1A2KMT2ACYP3A4
SCHEMBL21396138 0.95 PGR (0.47) MEN1ALDH1A1CYP1A2KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292169-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME LAGE3, PPOX, SUN2 MEN1 1034/4885ALDH1A1 91/4885CYP1A2 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.